Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3.
Mangia A, Bandiera F, Montalto G, Mottola L, Piazzolla V, Minerva N, Pellicelli A, Ricci GL, Cela M, Carretta V, Scotto G, Bacca D, Annicchiarico B, Romano M, Russello M, Barbarini G, Agostinacchio E, Andriulli A.
Mangia A, et al. Among authors: piazzolla v.
J Hepatol. 2010 Dec;53(6):1000-5. doi: 10.1016/j.jhep.2010.04.042. Epub 2010 Aug 4.
J Hepatol. 2010.
PMID: 20843575
Clinical Trial.